
Join to view full profile
110 Irving St NWWashington, DC 20010
Phone+1 202-877-7227
Fax+1 202-444-5104
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Laleh Amiri Kordestani, MD is an oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia and Maryland. She is affiliated with MedStar Georgetown University Hospital.
Education & Training
Tehran University of Medical Sciences School of MedicineClass of 2003
Certifications & Licensure
DC State Medical License 2013 - 2027
MD State Medical License 2009 - 2016
Publications & Presentations
PubMed
- Is Progression-Free Survival 2 Ready for Prime Time in US Food and Drug Administration Regulatory Decision Making?Mallorie H Fiero, Mirat Shah, Laleh Amiri-Kordestani
Journal of Clinical Oncology. 2026-07-10 - FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer.Nooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock, Xin Gao, William F Pierce
Clinical Cancer Research. 2026-04-15 - Reply to: Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.Mirat Shah, Mallorie H Fiero, Joyce Cheng, Ting-Yu Chen, Gwynn Ison
Journal of Clinical Oncology. 2025-12-20
Press Mentions
Special Session Explores Considerations Behind Breast Cancer Drug Approvals, TrialsDecember 15th, 2024









